Participants with Hearing Loss for Hearing Loss, Cochlear

Phase-Based Progress Estimates
Sonova - Kitchener, Kitchener, Canada
Hearing Loss, Cochlear+3 More
Hearing Aid - Variation #4 - Device
All Sexes
What conditions do you have?

Study Summary

Internal research on our hearing aid products has idenitfied areas in which we can improve the hearing aid frequency response curve. This study aims to investigate the current freqeuncy response curve in our products to variations to determine if hearing aid users prefer the variations over our standard curve.

Eligible Conditions

  • Hearing Loss, Cochlear
  • Bilateral Deafness

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 60 minutes

45 minutes
Sound Quality Rating - Live
60 minutes
Sound Quality Rating - Streamed

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Participants with Hearing Loss
1 of 1
Experimental Treatment

30 Total Participants · 1 Treatment Group

Primary Treatment: Participants with Hearing Loss · No Placebo Group · N/A

Participants with Hearing LossExperimental Group · 5 Interventions: Hearing Aid - Variation #4, Hearing Aid - Variation #2, Hearing Aid - Variation #1, Hearing Aid - Variation #3, Hearing Aid - Standard Curve · Intervention Types: Device, Device, Device, Device, Device

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 60 minutes
Closest Location: Sonova - Kitchener · Kitchener, Canada
N/AFirst Recorded Clinical Trial
0 TrialsResearching Hearing Loss, Cochlear
0 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 10 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are willing to wear a binaural fitting.
Experienced Users = more than 3 months of hearing aid experience.
You have symmetrical hearing loss.
You have no history of problematic tinnitus or pain/discomfort from loud sounds.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.